Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints
Biomolecules · 24.07.2026 · 16 (8) · 1085
DOI: 10.3390/biom16081085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 24.07.2026. Verfasst von Onural Ozhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Pharmacology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye. Hauptthemen laut MEDLINE: Doxorubicin, Sulfasalazine, Cardiotoxicity, Cardiotonic Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, Inonu University, Scientific and Technological Research Council of Türkiye.
Abstract (Originalsprache)
Anthracycline cardiotoxicity involves early oxidative–inflammatory injury to the myocardium and vasculature. Repurposing anti-inflammatory agents may offer pragmatic cardioprotection. The purpose of this study is to evaluate whether sulfasalazine (SSZ) mitigates doxorubicin (DOX)-induced myocardial and aortic injury in rats. Twenty-eight male Wistar albino rats were randomized to: Control (vehicle, n = 8), DOX (20 mg/kg i.p., single dose; n = 10), and SSZ + DOX (SSZ 300 mg/kg i.p. once daily for 3 days, then DOX 20 mg/kg i.p.; n = 10). At 24 h post-DOX, ECG and invasive blood pressure (BP) were recorded. The heart and thoracic aorta were harvested for histopathology and oxidative stress assays (MDA, SOD, GSH, CAT; composite indices where applicable). Compared with SSZ + DOX, the DOX group exhibited higher BP and greater arrhythmic burden. In the aorta, DOX elevated MDA and reduced SOD, GSH, and CAT versus the control, whereas SSZ + DOX shifted these toward control values. In the myocardium, DOX decreased SOD and increased oxidative index; SSZ + DOX attenuated histological injury (edema, hemorrhage, cardiomyocyte degeneration) and restored aortic intima–media thickness toward control. Heart rate was lower in SSZ + DOX than other groups. Short-course SSZ pretreatment alleviated early DOX-induced oxidative stress and structural damage in myocardial and aortic tissues, with concurrent improvement in hemodynamic and ECG profiles. These data support further dose–timing optimization and longer-term functional studies to define SSZ’s translational potential as an adjunct cardioprotective strategy during anthracycline exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Pharmacology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
- Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
- Department of Cardiology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
- Department of Histology and Embryology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
- Department of Physiology, Faculty of Medicine, Malatya Turgut Ozal University, 44210 Malatya, Türkiye.
- Department of Biostatistics and Medical Informatics, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
ORCID-Profile: Onural Ozhan, Mehmet Ertugrul Balkar, Azibe Yildiz, Feyzi Dogru, Zeynep Ulutas, Zeynep Kucukakcali, Hakan Parlakpinar
Förderung
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
- Inonu University
- Scientific and Technological Research Council of Türkiye
Zitieren
APA
Ozhan, O., Kaya, E., Tasolar, M. H., Balkar, M. E., Yildiz, A., Dogru, F., Ulutas, Z., Kucukakcali, Z., & Parlakpinar, H. (2026). Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints. Biomolecules, 16(8), 1085. https://doi.org/10.3390/biom16081085
Vancouver
Ozhan O, Kaya E, Tasolar MH, Balkar ME, Yildiz A, Dogru F, et al. Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints. Biomolecules. 2026;16(8):1085. doi:10.3390/biom16081085
BibTeX
@article{Ozhan2026,
author = {Ozhan, Onural and Kaya, Enes and Tasolar, Mehmet Hakan and Balkar, Mehmet Ertugrul and Yildiz, Azibe and Dogru, Feyzi and Ulutas, Zeynep and Kucukakcali, Zeynep and Parlakpinar, Hakan},
title = {Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {8},
pages = {1085},
doi = {10.3390/biom16081085}
}
EUVIMED